Biotech Values

[jbog]

Odac Voting:

Update 3:02 PM The FDA panel begins to vote on InterMune's perfinidone:

More from Adam Feuerstein Medivation's Next MovesInterMune Surges on FDA Drug ReviewDendreon: Biotech Stock Mailbag Market Activity InterMune Incorporated| ITMN UPDoes the data provide substantial evidence that pirfenidone provides a clinically meaningful beneficial effect in the treatment of patients with IPF to reduce decline in lung function? (Voting Question) If not, what further efficacy data should be obtained?
Yes 7 No 5.